Daily Equity Reports 05 Dec 2018

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 05TH DECEMBER 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 36134.31 INDIAN EQUITY BENCHMARK :- At the close of market hours, the Sensex closed down 106.69 points or 0.29% at 10869.50 36134.31, while the Nifty was lower by 14.30 points or 0.13% at ASIAN MARKET 10869.50. The market breadth is negative as 1154 shares CLOSE PREVIOUS advanced, against a decline of 1393 shares, while 143 shares NIKKEI 22036.05 were unchanged. GLOBAL FACE 27260.44 2131.93 ! SECTORIAL INDICES Asian Market - Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.42% and the Hang Seng rose 0.29%. The Nikkei 225 lost 2.39%. CLOSE CHANGE (%) 11086.40 -0.15 ! U.S. Market – Asian stocks mostly decline as 'warm fuzzy feeling' of US-China trade agreement fades. -0.11 ! -0.42 European markets - European markets are lower today with shares in -0.16 Germany off the most. The DAX is down 0.59% while London's FTSE 100 is off 0.52% and France's CAC 40 is lower by 0.48%. .BANK NIFTY 26693.80 -0.61 CLOSE CHANGE (%) BPCL 333 2.79 2.60 UPL 2.58 IBULHSGFIN 2.49 TOP LOSERS CLOSE CHANGE (%) 443 -2.72 M&M -2.55 845 -2.26 1942.85 -1.91 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE CHANGE (%) 3.89 STRATEGY SCRIPT CLOSE PIVOT POINTS P 10864 R1 R2 10921 RESISTANCE R1-10920 R2-10980 R3 10978 3.10 10750 10807 10838 10895 2.68 IBULHSGFIN SUPPORT S1-10810 S2-10750 2.67 MARKET MOVERS DOWNSIDE CHANGE (%) -3.87 CLOSE -3.30 BOSCH 1243.40 -3.17 APOLLOHOSP -2.75 FII & DII ACTIVITY NET BULLISH (CR.) PIVOT POINTS P 26831 5273.53 S3 S1 26738 R1 26911 R2 R3 26485 26658 DII 3487.98 RESISTANCE BANK NIFTY NSE TOTALS ADVANCE BANK NIFTY 4 8 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS Alembic Pharma subsidiary gets USFDA ! nod for Glycopyrrolate tablets Alembic Pharmaceuticals Ltd (Alembic), in a release to the exchanges on Tuesday, announced that its wholly-owned subsidiary Orit Laboratories LLC has received approval from the USFDA for its ANDA Glycopyrrolate tablets USP, 1 mg and 2 mg.According to IQVIA, Glycopyrrolate Tablets USP, 1 mg and 2 mg, had an estimated market size of $15mn to the twelve months ending December 2017. Govt not to participate in LIC’s open offer The government will not participate in Life Insurance Corporation’s (LIC) open offer to acquire a 51% controlling stake in IDBI Bank, the bank said in a press note the exchange on Tuesday."IDBI Bank is in a receipt of letter dated December 03, 2018, from the Government of India confirming that it will not participate in the open offer made by LIC," said the lender in a press note. ! GAIL to challenge CESTAT Delhi’s order GAIL, the natural gas processing and distribution company, is all set to challenge Customs Excise and Service Tax Appellate Tribunal (CESTAT) Delhi bench’s order of demand notice worth Rs2,822cr at forum."The company is passed by the CESTAT considering the merit of the case and well-reasoned order passed by the commissioner, while adjudicating higher order the view not ! the Special Centre for Nanoscience (SCNS). The company is going to challenge the order at higher forum and is confident of favorable outcome in this matter,” said the company in a press note to the exchanges on Monday after market hours. ! Domestic flat steel prices likely to face temporary pressures from cheaper imports Expectations of lenient production curbs in China during the winter months, and rising steel output amidst a seasonal moderation in demand have led to a steep correction in Chinese steel prices in November 2018. According to a recent ICRA research report, the threat of cheaper flat steel imports to India in the near term has increased and, as a result, domestic flat steel producers may have to brace for a downward revision in prices, especially in Q4FY19. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.